LSG2G

🌟 Reflecting on a memorable experience at BIO-Europe’s 30th anniversary in Stockholm! 🌟

Being part of the “Thank You for the Music” panel was such a privilege—an insightful, engaging conversation on life sciences, innovation, and the trends shaping our industry.

Special thanks to Millie Nelson for her excellent moderation, creating a space for each voice to shine and guiding the audience through the key takeaways.

And what a fantastic lineup alongside me: Cormac Sheridan Mike Ward and Jonathan Smith—each bringing unique insights and expertise that added incredible value to our discussion.

The full panel is available to rewatch in the partnering system for those who missed it.

A dynamic session filled with energy, perspectives, and future-focused ideas!

Big thanks to Michelle Cheesbrough and the entire EBD Group team for organizing such a memorable event. Your dedication and vision made this anniversary celebration a standout.

Now, I’m counting down to BIO-Europe 2025 in Vienna and already looking forward to reconnecting with everyone at BIO in Milan next spring.

You're the CEO of a promising startup, fresh off a Series B.

Things are looking good—but what happens next?

As you push for a Series C or even a D, the road narrows.

Fewer investors, fewer acquirers.

And raising the next round?

It’s not enough just to grow—you need to convince institutional investors you’re worth billions.

But how?

Here’s the harsh truth:

To let your VCs shine, you need to provide them with a 10x to 100x exit. That means, with a $500M valuation, your company needs to hit somewhere between $5 billion and $500 billion in value.

Think about it—how many companies can buy you out at that level? Not many.

But the public market can.

That’s where the big institutional players—people with a mindset like Charlie Munger—wait for opportunities.

And they are not looking for flashy startups; they want solid, long-term investment cases.

So, how do you make your company attractive to these investors?

It starts with understanding their mindset—just like Charlie Munger’s principles that guide the best in business and investing.

Step 1: 𝐌𝐚𝐬𝐭𝐞𝐫 𝐭𝐡𝐞 𝐀𝐫𝐭 𝐨𝐟 𝐈𝐧𝐯𝐞𝐫𝐬𝐢𝐨𝐧 𝐓𝐡𝐢𝐧𝐤𝐢𝐧𝐠
Munger teaches us to think backward—identify what could go wrong and work backward to avoid those pitfalls. As a CEO, this means understanding what makes institutional investors walk away and structuring your company to avoid these red flags.

Step 2: 𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐭𝐡𝐞 𝐑𝐢𝐠𝐡𝐭 𝐌𝐨𝐯𝐞𝐬
Just like compound interest builds wealth, small, consistent improvements in your company’s governance, culture, and financial health make you more attractive over time. The institutional investors you’re targeting are not impressed by fast growth—they’re looking for consistent, sustainable improvement.

Step 3: 𝐆𝐞𝐭 𝐭𝐡𝐞 𝐈𝐧𝐜𝐞𝐧𝐭𝐢𝐯𝐞𝐬 𝐑𝐢𝐠𝐡𝐭
What motivates your team today won’t cut it tomorrow. If you want to scale to a $5B+ valuation, you need to align your company's goals with those of public market investors—understanding the incentives that drive them.

When you apply these principles—avoiding cognitive biases, fostering the right culture, and aligning with investor expectations—you’re not just building a company; you’re building a long-term, investment-worthy powerhouse.

The kind of business that goes beyond a Series C and becomes a public market darling.

The reward?

You stop worrying about the next round and start preparing for an IPO—or, better yet, an acquisition exit that makes your VCs rave about you for decades. But it all starts with adopting the right mindset.

If you want to learn more about how to apply these timeless principles to your business, tune in to my latest podcast episode.

In this episode, I break down the 9 core principles from Poor Charlie’s Almanack that every CEO needs to know, especially when navigating the tricky waters of Series C and beyond.

Your success might depend on it!

🔗 Ready to dive deep into Charlie Munger’s wisdom and transform how you think about business and investing?

Here are the links you need:

🎧 Listen to the full podcast episode here: [https://www.buzzsprout.com/779930/episodes/15964204]

📺 Watch it on YouTube: [https://youtu.be/grVZJiHqSqg]

📚 Grab the book "Poor Charlie’s Almanack" on Amazon: [https://amzn.to/4hcJHMa]

Don’t miss out!

🚀 𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐄𝐮𝐫𝐨𝐩𝐞'𝐬 𝐓𝐞𝐜𝐡 𝐄𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧: 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐃𝐚𝐯𝐢𝐝 𝐃𝐚𝐧𝐚

I'm excited to present a new episode featuring a captivating conversation with David DANA, the mastermind at the European Investment Fund (EIF).

In this episode, David shares his insights on driving Europe's technological sovereignty. He delves into the transformative power of AI, Blockchain, and Quantum Technologies, and how these are shaping Europe's future in the global tech market.

Join us as we uncover how David's strategic vision and leadership at EIF are catalyzing Europe's journey towards becoming a technological powerhouse.

𝐇𝐞𝐫𝐞 𝐚𝐫𝐞 7 𝐨𝐟 𝐦𝐲 𝐛𝐢𝐠𝐠𝐞𝐬𝐭 𝐭𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬: 👇

🌍 𝐄𝐮𝐫𝐨𝐩𝐞'𝐬 𝐑𝐨𝐥𝐞 𝐢𝐧 𝐆𝐥𝐨𝐛𝐚𝐥 𝐓𝐞𝐜𝐡: [00:06:42]
"Europe has a role to play in the global market."

💡 𝐄𝐦𝐛𝐫𝐚𝐜𝐢𝐧𝐠 𝐑𝐢𝐬𝐤 𝐟𝐨𝐫 𝐑𝐞𝐰𝐚𝐫𝐝: [00:27:34]
"If you don't take the risk, you will not get the rewards."

🔬 𝐐𝐮𝐚𝐧𝐭𝐮𝐦 𝐓𝐞𝐜𝐡 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧: [00:34:50]
"Quantum technologies are at the beginning of something potentially huge."

🌐 𝐎𝐩𝐞𝐧𝐧𝐞𝐬𝐬 𝐢𝐧 𝐓𝐞𝐜𝐡 𝐓𝐫𝐚𝐧𝐬𝐟𝐞𝐫: [00:46:25]
"Opening to other shareholders helps to value and support the ecosystem more effectively."

💼 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 𝐃𝐞𝐩𝐥𝐨𝐲𝐦𝐞𝐧𝐭: [01:04:16]
"We need to generate returns; it's not just about investing, it's about deploying."

🧠 𝐄𝐮𝐫𝐨𝐩𝐞'𝐬 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐂𝐚𝐩𝐚𝐜𝐢𝐭𝐲: [01:20:30]
“Europe has the capacity, knowledge, and brains to innovate and change the world.”

🙌 𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩: [01:27:51]
"We need to empower others by trusting them, giving them autonomy and responsibility."

Tune in for an in-depth exploration of these topics and more. (Links to the full episode in the comments)

Which insights from David Dana resonated with you the most?

Like, comment, and share with those who would benefit from this content. Your support helps us grow the show and attract more incredible speakers like David, delivering insightful content for free. 🌟🇪🇺

🎄 Merry Christmas to The Facebook Community 🌟

In the spirit of the festive season, I'm excited to share my latest newsletter with you. It's a blend of reflection, gratitude, and insights from the world of deep tech, rooted in the philosophies that have shaped my journey.

🔗 Read the full letter here: [https://open.substack.com/pub/lsg2g/p/harmonizing-spirits-navigating-the?r=bxlfd&utm_campaign=post&utm_medium=web]

Join me as we explore the values of understanding, cooperation, and kindness, crucial for both life and the dynamic world of startups and investing.

Wishing everyone a season filled with peace, joy, and inspiration.

🌟 A Merry Christmas y’all - Christian Soschner

🌟 Exciting Podcast Alert! 🧠

Hey everyone! I'm thrilled to share the latest episode of our podcast where I had an insightful conversation with the brilliant Matias Serebrinsky from Psymed Ventures.

In this episode, we delve deep into the transformative world of mental health care, exploring how innovative approaches like psychedelic therapy and AI are reshaping the way we think about wellness and treatment.

🔍 Episode Highlights:

The groundbreaking potential of psychedelics in mental health care.
How AI and technology are revolutionizing treatment methods.
Matias's inspiring journey and the vision behind Psymed Ventures.
🎥 Watch the full episode here for an engaging and thought-provoking experience: https://youtu.be/3eOCZJqPKGY

🎧 Prefer just audio? Listen to our podcast while you're on the go: https://www.buzzsprout.com/779930/14125096

Join us in this eye-opening conversation and discover the future of mental health care. I'd love to hear your thoughts and takeaways in the comments below!

📌 𝐇𝐨𝐰 𝐜𝐚𝐧 𝐲𝐨𝐮 𝐬𝐭𝐚𝐲 𝐚𝐡𝐞𝐚𝐝 𝐢𝐧 𝐚𝐧 𝐞𝐯𝐨𝐥𝐯𝐢𝐧𝐠 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞? 🌍

In the face of high interest rates and shifting dynamics, the investment world is changing rapidly. But, for those well-equipped with the right strategies and insights, there's opportunity amidst the uncertainty. 📊

𝐇𝐞𝐫𝐞'𝐬 𝐰𝐡𝐚𝐭 𝐚𝐰𝐚𝐢𝐭𝐬 𝐲𝐨𝐮 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐰𝐞𝐞𝐤'𝐬 𝐧𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫:

🚀 𝐓𝐡𝐞 𝐈𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐨𝐟 𝐇𝐢𝐠𝐡-𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭 𝐑𝐚𝐭𝐞𝐬: Get insights on how this impacts startups, VCs, and LPs.
📈 𝐒𝐭𝐚𝐫𝐭𝐮𝐩 𝐚𝐧𝐝 𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 𝐃𝐞𝐦𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐬: Delve into what shapes the investment and VC landscapes.
🔍 𝐕𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧𝐬: Unravel the mysteries of market valuations and what they mean for your investments.

𝐃𝐨𝐧'𝐭 𝐦𝐢𝐬𝐬 𝐨𝐮𝐭 𝐨𝐧 𝐨𝐭𝐡𝐞𝐫 𝐞𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞𝐬 𝐥𝐢𝐤𝐞:
Latest articles and updates 📝
Inviting podcasts 🎧
Inspiring book recommendations 📚
Quotes to power your week 💪

🔗 Read the newsletter and ensure you stay at the forefront of the investment realm: https://lsg2g.substack.com/p/how-to-thrive-in-the-high-interest

And, if you find value in these insights, do consider subscribing for more monthly information. 💌

How to Thrive in the High-Interest Rate Era of 2023? Mastering the Investment Landscape Amidst Global Shifts

🔥 𝗖𝘂𝗿𝗶𝗼𝘂𝘀 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗱𝗲𝗲𝗽 𝘁𝗲𝗰𝗵 𝗮𝗻𝗱 𝗲𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿𝘀𝗵𝗶𝗽 𝗶𝗻 𝗔𝘂𝘀𝘁𝗿𝗶𝗮?

The Austria Startup Conference 2023 is where you'll find the answers, make valuable connections, and get a roadmap for success.

👉 𝗪𝗵𝘆 𝗔𝘁𝘁𝗲𝗻𝗱?
1️⃣ 𝗔𝗰𝘁𝗶𝗼𝗻𝗮𝗯𝗹𝗲 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: This isn't just another panel discussion. We're diving deep into topics that matter, from sustainability in business models to the future of fintech.

2️⃣ 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴: The attendee list reads like a who's who of the startup ecosystem—founders, investors, and industry experts. Don't miss the chance to expand your network.

3️⃣ 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗳𝗼𝗿 𝗦𝘂𝗰𝗰𝗲𝘀𝘀: Whether you're a founder or an investor, you'll walk away with strategies that you can implement immediately to make a difference.

🎙️ 𝗠𝗲𝗲𝘁 𝘁𝗵𝗲 𝗘𝘅𝗽𝗲𝗿𝘁𝘀:

Adam Fulham , a key player in the European startup network
Madeleine Tang , who's at the forefront of TikTok's business initiatives
Bjoern Schaettgen , a growth maestro at Match-Maker Ventures
Patrick Bartos , a climate tech venture builder
Robert Wesley , an AI and blockchain innovator
Alexey Kapustin , a leader in digital banking
Dr. Pius Sprenger , an angel investor with 20+ years of experience
Dr. Brigitta Schwarzer, MBA , an authority on governance and compliance

🚀 𝗗𝗼𝗻'𝘁 𝗠𝗶𝘀𝘀 𝗧𝗵𝗶𝘀 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆
Seats are limited and going fast.

If you're serious about leveling up your startup or investment game, this is a must-attend event.

Reserve your seat now: https://lnkd.in/di8RY3Pa

Check out the episode with Daniel Vitt, CEO of Immunic Therapeutics

💡Learn more about our clinical development pipeline of oral small molecule therapies for chronic inflammatory and autoimmune diseases in the LSG2G podcast with moderator Christian Soschner and our CEO & President, Dr. Daniel Vitt.

➡️ https://bit.ly/43JnPjH